As PKCα, a conventional PKC, is well recognized for its role in GBM cell proliferation [37], our results suggest that the inhibitory effect of B-FABP on GBM proliferation is potentially mediated by inhibition of PKCα as suggested by the decrease in conventional activity (Figure 2b). The gene discussed is FABP7; the disease is glioblastoma.